First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors von Ishihara, Mikiya, Tono, Yasutaka, Miyahara, Yoshihiro, Muraoka, Daisuke, Harada, Naozumi, Kageyama, Shinichi, Sasaki, Takeshi, Hori, Yasuhide, Soga, Norihito, Uchida, Katsunori, Shiraishi, Taizo, Sato, Eiichi, Kanda, Hideki, Mizuno, Toshiro, Webster, Gill A., Ikeda, Hiroaki, Katayama, Naoyuki, Sugimura, Yoshiki, Shiku, Hiroshi

Volltext

Combined use of pathological and genomic alteration analyses for the diagnosis of gray zone lymphoma von Nishimura, Komei, Miyazaki, Kana, Suzuki, Kazutaka, Hachiya, Kensuke, Tono, Yasutaka, Tamaru, Satoshi, Imai, Hiroshi, Miyoshi, Hiroaki, Ohshima, Koichi, Okugawa, Yoshinaga, Tawara, Isao, Yamaguchi, Motoko

Volltext

SMARCA2/BRM-Deficient Undifferentiated/Rhabdoid Carcinoma of Unknown Primary Site von Tono, Yasutaka, Sukeno, Koushi, Tsunoda, Akira, Saito, Kanako, Yamashita, Yoshiki, Usui, Miki, Uchida, Katsunori, Imai, Hiroshi, Mizuno, Toshiro, Tawara, Isao

Volltext

Atezolizumab-Induced Sarcoidosis-Like Reaction in a Patient with Metastatic Breast Cancer von Tsunoda, Akira, Mizuno, Toshiro, Iida, Shohei, Uchida, Katsunori, Yamashita, Masako, Sukeno, Koshi, Oka, Hiroki, Tono, Yasutaka, Ishihara, Mikiya, Saito, Kanako, Tamaru, Satoshi, Yamanaka, Keiichi, Tawara, Isao

Volltext

Successful treatment by prednisolone for interstitial pneumonia associated with anagrelide in a patient with essential thrombocythemia von Tamaru, Satoshi, Tono, Yasutaka, Matsumoto, Takeshi, Oda, Hiroyasu, Sugimoto, Yuka, Mizuno, Toshiro, Katayama, Naoyuki, Nishikawa, Masakatsu

Volltext

P40-3 Retrospective analysis of amrubicin therapy for advanced or recurrent neuroendocrine carcinoma in our facility von Tsunoda, Akira, Sukeno, Koshi, Oka, Hiroki, Tono, Yasutaka, Ishihara, Mikiya, Saito, Kanako, Tamaru, Satoshi, Yamashita, Yoshiki, Mizuno, Toshiro, Tawara, Isao

Volltext

Refractory Case of ALK-Negative Anaplastic Large-Cell Lymphoma with PAX-5 Expression and T-Cell Receptor-γ Gene Rearrangement von Kawakami, Keiki, Yazaki, Akira, Ito, Ryugo, Tono, Yasutaka, Murata, Tetsuya, Baba, Yohichiro, Uchiyama, Tomoko, Imai, Hiroshi, Nakamura, Shigeo

Volltext

MO36-3 Clinical management of cancer of unknown primary with unfavorable subset: A retrospective analysis von Tono, Yasutaka, Sukeno, Koushi, Tsunoda, Akira, Oka, Hiroki, Ishihara, Mikiya, Saito, Kanako, Tamaru, Satoshi, Yamashita, Yoshiki, Fujiwara, Takumi, Kitajima, Takahito, Okugawa, Yoshinaga, Mizuno, Toshiro

Volltext

MO16-3 Clinical relevance of comprehensive genome profiling using real-world data in colorectal cancer von Okugawa, Yoshinaga, Kitajima, Takahito, Fujiwara, Takumi, Teramoto, Emi, Nakamura, Maki, Ikejiri, Makoto, Hashizume, Ryotaro, Imai, Hiroshi, Tono, Yasutaka, Saito, Kanako, Mochiki, Ikuyo, Tamaru, Satoshi, Mizuno, Toshiro, Toiyama, Yuji

Volltext

A case of lupus erythematosus-like eruption under pembrolizumab administration von Matsuura, Yurie, Mizutani, Kento, Ichikawa, Ayaka, Tono, Yasutaka, Oka, Hiroki, Kondo, Makoto, Habe, Koji, Mizuno, Toshiro, Nakajima, Ayako, Yamanaka, Keiichi

Volltext

Orbital Inflammatory Lesion as an Initial Manifestation of Systemic Nasal Type NK/T-Cell Lymphoma von Kawakami, Keiki, Ito, Ryugo, Tono, Yasutaka, Yazaki, Akira, Murata, Tetsuya, Baba, Yohichiro, Uchiyama, Tomoko, Ito, Masafumi

Volltext

P1-9 Retrospective analysis of the efficacy and safety of FOLFOX in patients with esophageal cancer von Sukeno, Koshi, Tsunoda, Akira, Tono, Yasutaka, Oda, Hiroyasu, Ishihara, Mikiya, Saito, Kanako, Tamaru, Satoshi, Yamashita, Yoshiki, Mizuno, Toshiro

Volltext

P1-5 Retrospective analysis of the efficacy and safety of nivolumab in patients with treatment-refractory esophageal cancer von Kobayashi, Toshiaki, Oda, Hiroyasu, Sukeno, Koushi, Tsunoda, Akira, Tono, Yasutaka, Ishihara, Mikiya, Saito, Kanako, Yamashita, Yoshiki, Mizuno, Toshiro

Volltext

P14-4 A case of renal pelvic cancer treated with afatinib after reconsidering pathological diagnosis based on findings of CGP von Fujiwara, Takumi, Okugawa, Yoshinaga, Kitajima, Takahito, Saiki, Haruko, Tono, Yasutaka, Fujimoto, Hajime, Saito, Kanako, Hashizume, Ryotaro, Imai, Hiroshi, Mizuno, Toshiro, Kobayashi, Tetsu

Volltext

P52-5 Effort of Cancer Genome Center Hospital in Rural National University von Okugawa, Yoshinaga, Fujiwara, Takumi, Kitajima, Takahito, Nakamura, Maki, Ikejiri, Makoto, Sasaki, Takeshi, Yamada, Reiko, Uchida, Katsunori, Hashizume, Ryotaro, Imai, Hiroshi, Tono, Yasutaka, Saito, Kanako, Mochiki, Ikuyo, Mizuno, Toshiro, Toiyama, Yuji, Nakatani, Kaname

Volltext

The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis von Matsumoto, Takeshi, Kaneko, Toshihiro, Seto, Masashi, Wada, Hideo, Kobayashi, Toshihiko, Nakatani, Kaname, Tonomura, Harue, Tono, Yasutaka, Ohyabu, Mariko, Nobori, Tsutomu, Shiku, Hiroshi, Sudo, Akihiro, Uchida, Atsumasa, Stearns Kurosawa, Deborah J., Kurosawa, Shinichiro

Volltext

Analysis of biomarkers in a pilot study of pertuzumab, trastuzumab and eribulin for advanced HER2 positive breast cancer von Tono, Yasutaka, Ishihara, Mikiya, Miyahara, Yoshihiro, Ikeda, Hiroaki, Shiku, Hiroshi, Shiraishi, Taizo, Mizuno, Toshiro, Katayama, Naoyuki

Volltext

Cardiac angiosarcoma with pulmonary and adrenal metastases diagnosed by FDG-PET/CT-guided adrenal biopsy von Yamashita, Daiki, Fujimoto, Naoki, Okado, Ryo, Ikami, Akiyoshi, Yamamoto, Ayato, Tono, Yasutaka, Watanabe, Kiyotaka, Hayashi, Akinobu, Ota, Satoshi, Mizutani, Minoru, Kitamura, Tetsuya, Dohi, Kaoru

Volltext

CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression von Nagano, Mayuko, Saito, Kanako, Kozuka, Yuji, Ichishi, Masako, Yuasa, Hiroto, Noro, Aya, Imai, Nao, Shibusawa, Mai, Kimoto, Mao, Ishitobi, Makoto, Tono, Yasutaka, Oda, Hiroyasu, Ishihara, Mikiya, Mizuno, Toshiro, Ogawa, Tomoko, Katayama, Naoyuki

Volltext

First-in-human phase I clinical trial of NY-ESO-1 protein cancer vaccine with a novel adjuvant MIS416, NOD2 and TLR9 stimulant, for patients with NY-ESO-1 expressing solid tumors von Ishihara, Mikiya, Tono, Yasutaka, Miyahara, Yoshihiro, Harada, Naozumi, Kageyama, Shinichi, Sasaki, Takeshi, Hori, Yasuhide, Soga, Norihito, Uchida, Katsunori, Shiraishi, Taizo, Sato, Eiichi, Kanda, Hideki, Mizuno, Toshiro, Webster, Gill, Ikeda, Hiroaki, Katayama, Naoyuki, Sugimura, Yoshiki, Shiku, Hiroshi

Volltext